Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants

Baskent University26 enrolled

Overview

The objective of this study is to evaluate the efficacy and safety of sugammadex in reversing profound neuromuscular block induced by rocuronium in infant patients

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Brain Cancer

Interventions

SugammadexDRUG

Eligibility

Sex: ALLMin age: 1 MonthMax age: 12 Months

Medical Language ↔ Plain English

Inclusion Criteria: * Patients between the ages of 1-12 month, * ASA physical status 1-3 who underwent elective brain cancer surgery during general anesthesia were included in the study Exclusion Criteria: * younger than 1month or older than 12 months. * hepatic or renal failure * A history of allergy to study medication

Outcomes

Primary Outcomes

The efficacy of sugammadex were assessed by using Train of four (TOF)

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.